These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR, Gadducci A, Gambacciani M. Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941 [Abstract] [Full Text] [Related]
4. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Burger H. Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798 [Abstract] [Full Text] [Related]
6. Is HRT justified for symptom management in women at higher risk of developing breast cancer? Rippy L, Marsden J. Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372 [Abstract] [Full Text] [Related]
10. Hormone replacement therapy in breast cancer survivors. Xydakis AM, Sakkas EG, Mastorakos G. Ann N Y Acad Sci; 2006 Dec 20; 1092():349-60. PubMed ID: 17308160 [Abstract] [Full Text] [Related]
11. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M. J Cardiovasc Med (Hagerstown); 2009 Apr 20; 10(4):303-9. PubMed ID: 19430340 [Abstract] [Full Text] [Related]
12. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society. Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103 [Abstract] [Full Text] [Related]
14. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?]. Ayres de Campos D, Barros H, Martinez de Oliveira J. Acta Med Port; 1997 Oct 16; 10(10):697-703. PubMed ID: 9477595 [Abstract] [Full Text] [Related]
16. Hormone replacement therapy in postmenopausal women. Yasui T, Uemura H, Takikawa M, Irahara M. J Med Invest; 2003 Aug 16; 50(3-4):136-45. PubMed ID: 13678382 [Abstract] [Full Text] [Related]
17. Are older breast carcinoma survivors willing to take hormone replacement therapy? Ganz PA, Greendale GA, Kahn B, O'Leary JF, Desmond KA. Cancer; 1999 Sep 01; 86(5):814-20. PubMed ID: 10463980 [Abstract] [Full Text] [Related]
18. [Which is the better choice, estrogen or SERMs in postmenopausal women?]. Shintani M. Clin Calcium; 2004 Oct 01; 14(10):105-10. PubMed ID: 15577140 [Abstract] [Full Text] [Related]
19. [Hormone replacement therapy in breast cancer survivors: the Israeli Society for Clinical Oncology and Radiotherapy policy letter]. Siegelmann-Danieli N, Ron I, Kaufman B, Uzieli B, Karminsky N, Inbar M, Israeli Society for Clinical Oncology and Radiotherapy. Harefuah; 2004 Oct 01; 143(10):753-6, 764. PubMed ID: 15521355 [Abstract] [Full Text] [Related]
20. Management of menopause in women with breast cancer. Brzezinski A. Isr J Med Sci; 1995 Oct 01; 31(2-3):163-8. PubMed ID: 7744587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]